Skip to main content

ORACEA Capsules Provide Multiple Benefits Over Doxycycline 100 mg2,3 ORACEA Capsules Doxycycline 100 mg

Favorable GI tolerability compared to 100 mg2

  • In a head-to-head clinical study, no nausea, diarrhea or vomiting were reported for ORACEA Capsules (vs. 17.3%, 4.3%, and 4.3% for doxycycline 100 mg)
     
  • In pivotal clinical studies, the most common treatment-related adverse events (>2%) for ORACEA Capsules were nasopharyngitis (4.8%), diarrhea (4.5%), hypertension (3%), sinusitis (2.6%) and aspartate aminotransferase increase (2.2%).
Yes No

No evidence of bacterial resistance3

In a 9-month study

Yes No

No photosensitivity or vaginal candidiasis reported in controlled clinical studies3

Yes No